TABLE 2.
Univariate Crude OR (95% CI) | Model 1: aOR (95% CI) | Model 2: aOR (95% CI) | |
---|---|---|---|
Age group | Not significant | - | - |
Race/ethnicitya | Not significant | - | - |
Regionb | |||
North/Sac | Ref | Ref | Ref |
Bay Area | 1.2 (0.5–2.7) | 1.6 (0.7–3.7) | 1.8 (0.7–4.7) |
Central | 2.0 (1.1–3.6) | 2.4 (1.3–4.4) | 2.1 (1.1–4.2) |
South | 1.7 (0.9–3.2) | 2.3 (1.2–4.5) | 2.1 (0.99–4.3) |
Ever diagnosed STDc | Not significant | - | - |
Meth use5 | |||
Yes | 2.3 (1.7–3.2) | 2.1 (1.4–3.1) | 1.5 (0.96–2.4) |
No | Ref | Ref | Ref |
Incarcerationd | Not significant | - | - |
Homelessness | |||
Yes | 2.7 (1.8–4.1) | 2.5 (1.6–4.0) | 1.7 (0.99–2.9) |
No | Ref | Ref | Ref |
IDUd | Not significant | - | - |
Partner methd | - | ||
Yes | 1.6 (1.1–2.2) | 0.8 (0.5–1.2) | 0.7 (0.4–1.2) |
No | Ref | Ref | Ref |
Partner incarceratedd | Not significant | - | - |
Stage | |||
Early | 2.2 (1.6–3.0) | 2.2 (1.6–3.1) | 2.6 (1.8–3.7) |
Late | Ref | Ref | Ref |
Gest. age first PNC | |||
At or before 20 weeks | Ref | - | Ref |
After 20 weeks | 2.9 (2.0–4.2) | - | 2.9 (1.9–4.2) |
None | 18.5 (10.6–32.3) | - | 16.7 (9.2–30.3) |
Note: In univariate analyses, the following were significantly associated with delivering an infant with CS: having received no or late prenatal care; homelessness; methamphetamine use; living in the Central region; early stage; and partner methamphetamine use. In the final Model 2, having received late or no prenatal care; early stage of syphilis; living in the Central region remained associated with CS. However, birthing parents experiencing homelessness or methamphetamine use were not more likely to have infants with CS compared with birthing parents without these characteristics. Bold values are statistically significant.
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; CS, congenital syphilis; STD, sexually transmitted diseases.
Race/ethnicity missing for 25 females.
San Francisco and Los Angeles local health jurisdictions are excluded.
Ever diagnosed with an STD includes diagnosis with chlamydia, gonorrhea, or syphilis.
Timing is within the last 12 months.